Antitargets and drug safety:
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Weinheim
Wiley-VCH
2015
|
| Schriftenreihe: | Methods and principles in medicinal chemistry
v. 66 |
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 Volltext |
| Beschreibung: | Description based upon print version of record Includes bibliographical references and index With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing |
| Beschreibung: | 1 Online-Ressource (1266 p.) |
| ISBN: | 9783527673643 3527673644 9783527673674 3527673679 9783527673667 3527673660 9783527335114 3527335110 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV043397595 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9783527673643 |c electronic bk |9 978-3-527-67364-3 | ||
| 020 | |a 3527673644 |c electronic bk |9 3-527-67364-4 | ||
| 020 | |a 9783527673674 |c electronic bk |9 978-3-527-67367-4 | ||
| 020 | |a 3527673679 |c electronic bk |9 3-527-67367-9 | ||
| 020 | |a 9783527673667 |9 978-3-527-67366-7 | ||
| 020 | |a 3527673660 |9 3-527-67366-0 | ||
| 020 | |a 9783527335114 |9 978-3-527-33511-4 | ||
| 020 | |a 3527335110 |9 3-527-33511-0 | ||
| 020 | |a 9783527335114 |9 978-3-527-33511-4 | ||
| 024 | 7 | |a 10.1002/9783527673643 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn904518353 | ||
| 035 | |a (OCoLC)904518353 | ||
| 035 | |a (DE-599)BVBBV043397595 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615.19 |2 23 | |
| 245 | 1 | 0 | |a Antitargets and drug safety |c edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz |
| 264 | 1 | |a Weinheim |b Wiley-VCH |c 2015 | |
| 300 | |a 1 Online-Ressource (1266 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Methods and principles in medicinal chemistry |v v. 66 | |
| 500 | |a Description based upon print version of record | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing | ||
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs / Design | |
| 650 | 4 | |a Medicine | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drug interactions |2 fast | |
| 650 | 7 | |a Drugs / Design |2 fast | |
| 650 | 7 | |a Drugs / Side effects |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs / Design | |
| 650 | 4 | |a Drugs / Side effects | |
| 650 | 4 | |a Drug interactions | |
| 653 | |a Electronic books | ||
| 700 | 1 | |a Urbán, László |e Sonstige |4 oth | |
| 700 | 1 | |a Patel, Vinod |e Sonstige |4 oth | |
| 700 | 1 | |a Vaz, Roy J. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028816179 | ||
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175979918131200 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV043397595 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn904518353 (OCoLC)904518353 (DE-599)BVBBV043397595 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03116nmm a2200685zcb4500</leader><controlfield tag="001">BV043397595</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527673643</subfield><subfield code="c">electronic bk</subfield><subfield code="9">978-3-527-67364-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527673644</subfield><subfield code="c">electronic bk</subfield><subfield code="9">3-527-67364-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527673674</subfield><subfield code="c">electronic bk</subfield><subfield code="9">978-3-527-67367-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527673679</subfield><subfield code="c">electronic bk</subfield><subfield code="9">3-527-67367-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527673667</subfield><subfield code="9">978-3-527-67366-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527673660</subfield><subfield code="9">3-527-67366-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527335114</subfield><subfield code="9">978-3-527-33511-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527335110</subfield><subfield code="9">3-527-33511-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527335114</subfield><subfield code="9">978-3-527-33511-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9783527673643</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn904518353</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)904518353</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043397595</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antitargets and drug safety</subfield><subfield code="c">edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim</subfield><subfield code="b">Wiley-VCH</subfield><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (1266 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Methods and principles in medicinal chemistry</subfield><subfield code="v">v. 66</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug interactions</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Design</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Side effects</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Side effects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Electronic books</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Urbán, László</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patel, Vinod</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Vaz, Roy J.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028816179</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043397595 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:54Z |
| institution | BVB |
| isbn | 9783527673643 3527673644 9783527673674 3527673679 9783527673667 3527673660 9783527335114 3527335110 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028816179 |
| oclc_num | 904518353 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (1266 p.) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Wiley-VCH |
| record_format | marc |
| series2 | Methods and principles in medicinal chemistry |
| spelling | Antitargets and drug safety edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz Weinheim Wiley-VCH 2015 1 Online-Ressource (1266 p.) txt rdacontent c rdamedia cr rdacarrier Methods and principles in medicinal chemistry v. 66 Description based upon print version of record Includes bibliographical references and index With its focus on emerging concerns of kinase and GPCR-mediated antitarget effects, this vital reference for drug developers addresses one of the hot topics in drug safety now and in future. Divided into three major parts, the first section deals with novel technologies and includes the utility of adverse event reports to drug discovery, the translational aspects of preclinical safety findings, broader computational prediction of drug side-effects, and a description of the serotonergic system. The main part of the book looks at some of the most common antitarget-mediated side effects, focusing Drug development Drugs / Design Medicine MEDICAL / Pharmacology bisacsh Drug development fast Drug interactions fast Drugs / Design fast Drugs / Side effects fast Medizin Drugs / Side effects Drug interactions Electronic books Urbán, László Sonstige oth Patel, Vinod Sonstige oth Vaz, Roy J. Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Antitargets and drug safety Drug development Drugs / Design Medicine MEDICAL / Pharmacology bisacsh Drug development fast Drug interactions fast Drugs / Design fast Drugs / Side effects fast Medizin Drugs / Side effects Drug interactions |
| title | Antitargets and drug safety |
| title_auth | Antitargets and drug safety |
| title_exact_search | Antitargets and drug safety |
| title_full | Antitargets and drug safety edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz |
| title_fullStr | Antitargets and drug safety edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz |
| title_full_unstemmed | Antitargets and drug safety edited by Laszlo Urban, Vinod F. Patel and Roy J. Vaz |
| title_short | Antitargets and drug safety |
| title_sort | antitargets and drug safety |
| topic | Drug development Drugs / Design Medicine MEDICAL / Pharmacology bisacsh Drug development fast Drug interactions fast Drugs / Design fast Drugs / Side effects fast Medizin Drugs / Side effects Drug interactions |
| topic_facet | Drug development Drugs / Design Medicine MEDICAL / Pharmacology Drug interactions Drugs / Side effects Medizin |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9783527673643 |
| work_keys_str_mv | AT urbanlaszlo antitargetsanddrugsafety AT patelvinod antitargetsanddrugsafety AT vazroyj antitargetsanddrugsafety |